# Totally Transdermal Sedation in the Weaning From Remifentanil Infusion

> **NCT04204967** · PHASE2 · COMPLETED · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 24 (actual)

## Conditions studied

- Respiratory Insufficiency
- Ventilator Weaning
- Analgesics, Opioid

## Interventions

- **DRUG:** Fentanyl Transdermal System
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT04204967
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-15
- **Primary completion:** 2024-04-06
- **Final completion:** 2024-04-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04204967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04204967, "Totally Transdermal Sedation in the Weaning From Remifentanil Infusion". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04204967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*